Role of p53 in the cellular response following oleic acid accumulation in Chang liver cells

Toxicology Letters

Volumn 224, Issue 1, 2014, Pages 114-120

  Park, Eun Jung ^a   Lee, Ah Young ^b   Chang, Seung Hee ^b   Yu, Kyeong Nam ^b   Kim, Jae Ho ^a   Cho, Myung Haing ^b,c  

^a Ajou University   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

ATP; Autophagy; Lipophagy; Oleic acid; P53

Indexed keywords

ADENOSINE TRIPHOSPHATE; OLEIC ACID; PERILIPIN; PIFITHRIN ALPHA; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; HELA CELL; HUMAN; HUMAN CELL; LIPID STORAGE; LIPOPHAGOCYTOSIS; LIPOTOXICITY; LIVER CELL; LIVER MITOCHONDRION; LYSOSOME; MICROAUTOPHAGY; PRIORITY JOURNAL; PROTEIN FUNCTION;

ATP; AUTOPHAGY; LIPOPHAGY; OLEIC ACID; P53;

ADENOSINE TRIPHOSPHATE; CELL CYCLE; CELL SURVIVAL; CELLS, CULTURED; HEPATOCYTES; HUMANS; OLEIC ACID; REACTIVE OXYGEN SPECIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84887511490     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.09.018     Document Type: Article

References (47)

1. Alkhouri N., Dixon L.J., Feldstein A.E. Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal. Expert Rev. Gastroenterol. Hepatol. 2009, 3(4):445-451.
2. Balaburski G.M., Hontz R.D., Murphy M.E. p53 and ARF: unexpected players in autophagy. Trends Cell Biol. 2010, 20(6):363-369.
3. Calder P.C., Yaqoob P., Thies F., Wallace F.A., Miles E.A. Fatty acids and lymphocyte functions. Br. J. Nutr. 2002, 87(Suppl. 1):S31L 48.
4. Carrillo C., Cavia Mdel M., Alonso-Torre S.R. Antitumor effect of oleic acid; mechanisms of action: a review. Nutr. Hosp. 2012, 27(6):1860-1865.
5. Chaabane W., User S.D., El-Gazzah M., Jaksik R., Sajjadi E., Rzeszowska-Wolny J., Los M.J. Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer. Arch. Immunol. Ther. Exp. (Warsz) 2013, 61(1):43-58.
6. Christian P., Sacco J., Adeli K. Autophagy: emerging roles in lipid homeostasis and metabolic control. Biochim. Biophys. Acta 2013, 1831(4):819-824.
7. Crighton D., Wilkinson S., Ryan K.M. DRAM links autophagy to p53 and programmed cell death. Autophagy 2007, 3(1):72-74.
8. Dedukhova V.I., Mokhova E.N., Skulachev V.P., Starkov A.A., Arrigoni-Martelli E., Bobyleva V.A. Uncoupling effect of fatty acids on heart muscle mitochondria and submitochondrial particles?. FEBS Lett. 1991, 295(1-3):51-54.
9. Dunn L.L., Suryo Rahmanto Y., Richardson D.R. Iron uptake and metabolism in the new millennium. Trends Cell Biol. 2007, 17(2):93-100.
10. Feng Z. p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment. Cold Spring Harb. Perspect. Biol. 2010, 2(2):a001057.
11. Galluzzi L., Vitale I., Abrams J.M., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2012, 19(1):107-120.
12. Goldstein I., Ezra O., Rivlin N., Molchadsky A., Madar S., Goldfinger N., Rotter V. p53, a novel regulator of lipid metabolism pathways. J. Hepatol. 2012, 56(3):656-662.
13. Gudkov A.V., Komarova E.A. Prospective therapeutic applications of p53 inhibitors. Biochem. Biophys. Res. Commun. 2005, 331(3):726-736.
14. http://www.atcc.org/Products/All/CCL-13.aspx%2385786B46AA23451B94BC5D45200673F7.
15. Ip C Review of the effects of trans fatty acids, oleic acid, n-3 polyunsaturated fatty acids, and conjugated linoleic acid on mammary carcinogenesis in animals. Am. J. Clin. Nutr. 1997, 66(6 Suppl.):1523S-1529S.
16. Jiang P., Du W., Wang X., Mancuso A., Gao X., Wu M., Yang X. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat. Cell Biol. 2011, 13(3):310-316.
17. Jin S. p53, autophagy and tumor suppression. Autophagy 2005, 1(3):171-173.
18. Kalinowski D.S., Richardson D.R. The evolution of iron chelators for the treatment of iron overload disease and cancer. Pharmacol. Rev. 2005, 57(4):547-583.
19. Klionsky D.J., Abdalla F.C., Abeliovich H., Abraham R.T., Acevedo Arozena A., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8(4):445-544.
20. 2 by mitochondria in the resting state. FEBS Lett. 1998, 435(2-3):215-218.
21. Kraegen E.W., Cooney G.J., Ye J.M., Thompson A.L., Furler S.M. The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity. Exp. Clin. Endocrinol. Diabetes 2001, 109(Suppl. 2):S189-S201.
22. Kroemer G., Galluzzi L., Vandenabeele P., Abrams J., Alnemri E.S., Baehrecke E.H., et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009, 16(1):3-11.
23. Kurz T., Gustafsson B., Brunk U.T. Cell sensitivity to oxidative stress is influenced by ferritin autophagy. Free Radic. Biol. Med. 2011, 50(11):1647-1658.
24. Listenberger L.L., Han X., Lewis S.E., Cases S., Farese R.V., Ory D.S., Schaffer J.E. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl. Acad. Sci. U.S.A. 2003, 100(6):3077-3082.
25. Lorin S., Pierron G., Ryan K.M., Codogno P., Djavaheri-Mergny M. Evidence for the interplay between JNK and p53-DRAM signaling pathways in the regulation of autophagy. Autophagy 2010, 6(1):153-154.
26. Mei S., Ni H.M., Manley S., Bockus A., Kassel K.M., Luyendyk J.P., Copple B.L., Ding W.X. Differential roles of unsaturated and saturated fatty acids on autophagy and apoptosis in hepatocytes. J. Pharmacol. Exp. Ther. 2011, 339(2):487-498.
27. Mokhova E.N., Khailova L.S. Involvement of mitochondrial inner membrane anion carriers in the uncoupling effect of fatty acids. Biochemistry (Mosc) 2005, 70(2):159-163.
28. Moscat J., Diaz-Meco M.T. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 2009, 137(6):1001-1004.
29. Nolan C.J., Larter C.Z. Lipotoxicity: why do saturated fatty acids cause and monounsaturates protect against it?. J. Gastroenterol. Hepatol. 2009, 24(5):703-706.
30. Pacher P., Szabo C. Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am. J. Pathol. 2008, 173(1):2-13.
31. Park E.J., Yi J., Kim Y., Choi K., Park K. Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol. In Vitro 2010, 24(3):872-878.
32. Park E.J., Yi J., Chung K.H., Ryu D.Y., Choi J., Park K. Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells. Toxicol. Lett. 2008, 180(3):222-229.
33. Pieper A.A., Verma A., Zhang J., Snvder S.H. Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol. Sci. 1999, 20(4):171-181.
34. Ricchi M., Odoardi M.R., Carulli L., Anzivino C., Ballestri S., Pinetti A., Fantoni L.I., Marra F., Bertolotti M., Banni S., Lonardo A., Carulli N., Loria P. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. J. Gastroenterol. Hepatol. 2009, 24(5):830-840.
35. Schaffer J.E. Lipotoxicity: when tissues overeat. Curr. Opin. Lipidol. 2003, 14(3):281-287.
36. Schönfeld P., Wojtczak L. Fatty acids as modulators of the cellular production of reactive oxygen species. Free Radic. Biol. Med. 2008, 45(3):231-241.
37. Schrauwen P., Hesselink M.K. Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 2004, 53(6):1412-1417.
38. Singh R. Autophagy and regulation of lipid metabolism. Results Probl. Cell Differ. 2010, 52:35-46.
39. Singh R., Cuervo A.M. Lipophagy: connecting autophagy and lipid metabolism. Int. J. Cell Biol. 2012, 2012:282041.
40. Singh R., Kaushik S., Wang Y., Xiang Y., Novak I., Komatsu M., Tanaka K., Cuervo A.M., Czaja M.J. Autophagy regulates lipid metabolism. Nature 2009, 458(7242):1131-1135.
41. Sivitz W.I. Lipotoxicity and glucotoxicity in type 2 diabetes. Effects on development and progression. Postgrad. Med. 2001, 109(4):63-64. 55-59.
42. Unger R.H. Lipotoxic diseases. Annu. Rev. Med. 2002, 53:319-336.
43. Vousden K.H., Ryan K.M. p53 and metabolism. Nat. Rev. Cancer 2009, 9(10):691-700.
44. Weinberg J.M. Lipotoxicity. Kidney Int. 2006, 70(9):1560-1566.
45. Wendel M., Heller A.R. Mitochondrial function and dysfunction. Wien. Med. Wochenschr. 2010, 160(5-6):118-123.
46. Yaqoob P. Monosaturated fatty acids and immune function. Eur. J. Clin. Nutr. 2002, 56(Suppl. 3):S9L S13.
47. Zhang X.D., Qin Z.H., Wang J. The role of p53 in cell metabolism. Acta Pharmacol. Sin. 2010, 31(9):1208-1212.